A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression
- Dominguez-Mozo, M.I.
- Galán, V.
- Ramió-Torrentà, L.
- Quiroga, A.
- Quintana, E.
- Villar, L.M.
- Costa-Frossard, L.
- Fernández-Velasco, J.I.
- Villarrubia, N.
- Garcia-Martinez, M.A.
- Arroyo, R.
- Alvarez-Lafuente, R.
Journal:
Frontiers in Immunology
ISSN: 1664-3224
Year of publication: 2024
Volume: 15
Type: Article